By Ian Gilson, PhD, CFA NASDAQ:MBII READ THE FULL MBII RESEARCH REPORT Marrone Bio Innovations (NASDAQ:MBII) has announced that it has received the first approval of the use of REGALIA MAXX biofungicide for the use on cannabis and hemp (hemp and marijuana are two varieties of the same plant cannabis sativa) in Canada. Cannabis is susceptible to powdery mildew. It can destroy complete crops and
Marrone Bio Innovations, Inc. (MBII) (MBI), an international leader in sustainable bioprotection and plant health solutions, announced today that REGALIA® MAXX biofungicide received the first approval for indoor and outdoor use on cannabis and hemp in Canada. Cannabis and hemp have been relatively small crops in Canada until lifestyle cannabis was approved in 2018. According to Health Canada, 77,800 acres of hemp were grown in 2018, valued at an estimated $50 million USD.
Gainers Driven Deliveries (OTC: DRVD ) shares closed up 24.09% at $0.85 Item 9 Labs (OTC: INLB ) shares closed up 13.32% at $0.85 Marrone Bio Innovations (NASDAQ: MBII ) shares closed up 11.83% at $1.04 Cann Group (OTC: CNGGF ) shares closed up 11.4% at $0.63 NexTech AR Solns (OTC: NEXCF ) … Full story available on Benzinga.com